Electrographic Flow (EGF) mapping with Ablamap is a novel technique to create full temporospatial visualizations of organized action potential flow within chaotic conduction of Atrial Fibrillation. Ablacon has built a premier machine intelligence system to quantitatively and qualitatively understand and treat atrial fibrillation (AF).
Electrographic Flow mapping and ablation therapy
Ablamap reveals action potential flow
Electrographic Flow helps understand Atrial Fibrillation
Phenomena revealed by Electrographic Flow mapping are related to the initiation and maintenance of AF.
Caution: Not commercially available in the United States. Limited to investigational use.
Ablacon in the news
- Ablacon Announces Release of New and Improved Ablamap Technology Under Existing CE Mark
- Ablacon Announces Closing of a $10 Million Venture Debt Facility and $2 Million Equity Investment from Western Technology Investment; Josef Koblish and Melissa Kong to Join the Company
- Forbes lists Ablacon “25 Top Machine Learning Startups To Watch In 2019”
- Ablacon, Inc. Raises $21.5M Series A to Advance AI-Enabled Atrial Fibrillation Mapping System